Structure-guided combination therapy to potently improve the function of mutant CFTRs
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Structure-guided combination therapy to potently improve the function of mutant CFTRs
Authors
Keywords
-
Journal
NATURE MEDICINE
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-09-27
DOI
10.1038/s41591-018-0200-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mutation-specific downregulation of CFTR2 variants by gating potentiators
- (2017) Radu G Avramescu et al. HUMAN MOLECULAR GENETICS
- Stabilization of a nucleotide-binding domain of the cystic fibrosis transmembrane conductance regulator yields insight into disease-causing mutations
- (2017) Robert M. Vernon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Conditional reprogramming and long-term expansion of normal and tumor cells from human biospecimens
- (2017) Xuefeng Liu et al. Nature Protocols
- Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del
- (2017) Jennifer L. Taylor-Cousar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chaperones rescue the energetic landscape of mutant CFTR at single molecule and in cell
- (2017) Miklos Bagdany et al. Nature Communications
- Correction of CFTR function in nasal epithelial cells from cystic fibrosis patients predicts improvement of respiratory function by CFTR modulators
- (2017) Iwona M. Pranke et al. Scientific Reports
- A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR
- (2016) A Tosco et al. CELL DEATH AND DIFFERENTIATION
- Analysis of nasal potential in murine cystic fibrosis models
- (2016) Mélanie Faria da Cunha et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations
- (2016) Gudio Veit et al. MOLECULAR BIOLOGY OF THE CELL
- Binding screen for cystic fibrosis transmembrane conductance regulator correctors finds new chemical matter and yields insights into cystic fibrosis therapeutic strategy
- (2016) Justin D. Hall et al. PROTEIN SCIENCE
- Ribosomal Stalk Protein Silencing Partially Corrects the ΔF508-CFTR Functional Expression Defect
- (2016) Guido Veit et al. PLOS BIOLOGY
- Combination of Correctors Rescue ΔF508-CFTR by Reducing Its Association with Hsp40 and Hsp27
- (2015) Miquéias Lopes-Pacheco et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Restoration of NBD1 Thermal Stability Is Necessary and Sufficient to Correct ∆F508 CFTR Folding and Assembly
- (2015) Lihua He et al. JOURNAL OF MOLECULAR BIOLOGY
- RNA Interference Screen to Identify Kinases That Suppress Rescue of ΔF508-CFTR
- (2015) Agata M. Trzcińska-Daneluti et al. MOLECULAR & CELLULAR PROTEOMICS
- ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis
- (2015) Sandra Pankow et al. NATURE
- Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR
- (2015) Claire E. Wainwright et al. NEW ENGLAND JOURNAL OF MEDICINE
- Unravelling druggable signalling networks that control F508del-CFTR proteostasis
- (2015) Ramanath Narayana Hegde et al. eLife
- Constrained Bithiazoles: Small Molecule Correctors of Defective ΔF508–CFTR Protein Trafficking
- (2014) Keith C. Coffman et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cystic fibrosis genetics: from molecular understanding to clinical application
- (2014) Garry R. Cutting NATURE REVIEWS GENETICS
- Some gating potentiators, including VX-770, diminish F508-CFTR functional expression
- (2014) G. Veit et al. Science Translational Medicine
- Potentiator ivacaftor abrogates pharmacological correction of F508 CFTR in cystic fibrosis
- (2014) D. M. Cholon et al. Science Translational Medicine
- Modulation of the Maladaptive Stress Response to Manage Diseases of Protein Folding
- (2014) Daniela Martino Roth et al. PLOS BIOLOGY
- Revertants, Low Temperature, and Correctors Reveal the Mechanism of F508del-CFTR Rescue by VX-809 and Suggest Multiple Agents for Full Correction
- (2013) Carlos M. Farinha et al. CHEMISTRY & BIOLOGY
- Effect of ivacaftor on CFTR forms with missense mutations associated with defects in protein processing or function
- (2013) Fredrick Van Goor et al. Journal of Cystic Fibrosis
- Ubiquitination-dependent quality control of hERG K+ channel with acquired and inherited conformational defect at the plasma membrane
- (2013) Pirjo M. Apaja et al. MOLECULAR BIOLOGY OF THE CELL
- VX-809 corrects folding defects in cystic fibrosis transmembrane conductance regulator protein through action on membrane-spanning domain 1
- (2013) Hong Yu Ren et al. MOLECULAR BIOLOGY OF THE CELL
- Mechanism-based corrector combination restores ΔF508-CFTR folding and function
- (2013) Tsukasa Okiyoneda et al. Nature Chemical Biology
- Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene
- (2013) Patrick R Sosnay et al. NATURE GENETICS
- Characterization of Nasal Potential Difference in cftr Knockout and F508del-CFTR Mice
- (2013) Emilie Lyne Saussereau et al. PLoS One
- The CFTR Ion Channel: Gating, Regulation, and Anion Permeation
- (2013) T.-C. Hwang et al. Cold Spring Harbor Perspectives in Medicine
- Requirements for Efficient Correction of ΔF508 CFTR Revealed by Analyses of Evolved Sequences
- (2012) Juan L. Mendoza et al. CELL
- Correction of Both NBD1 Energetics and Domain Interface Is Required to Restore ΔF508 CFTR Folding and Function
- (2012) Wael M. Rabeh et al. CELL
- CFTR regulation in human airway epithelial cells requires integrity of the actin cytoskeleton and compartmentalized cAMP and PKA activity
- (2012) S. Monterisi et al. JOURNAL OF CELL SCIENCE
- Proinflammatory cytokine secretion is suppressed by TMEM16A or CFTR channel activity in human cystic fibrosis bronchial epithelia
- (2012) Guido Veit et al. MOLECULAR BIOLOGY OF THE CELL
- ROCK Inhibitor and Feeder Cells Induce the Conditional Reprogramming of Epithelial Cells
- (2011) Xuefeng Liu et al. AMERICAN JOURNAL OF PATHOLOGY
- Protein quality control at the plasma membrane
- (2011) Tsukasa Okiyoneda et al. CURRENT OPINION IN CELL BIOLOGY
- V2 Vasopressin Receptor (V2R) Mutations in Partial Nephrogenic Diabetes Insipidus Highlight Protean Agonism of V2R Antagonists
- (2011) Kazuhiro Takahashi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Small-molecule proteostasis regulators for protein conformational diseases
- (2011) Barbara Calamini et al. Nature Chemical Biology
- Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809
- (2011) F. Van Goor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition of Ca2+-activated Cl− channels by gallotannins as a possible molecular basis for health benefits of red wine and green tea
- (2010) Wan Namkung et al. FASEB JOURNAL
- CFTR chloride channel in the apical compartments: spatiotemporal coupling to its interacting partners
- (2010) Chunying Li et al. Integrative Biology
- The Cystic Fibrosis-causing Mutation ΔF508 Affects Multiple Steps in Cystic Fibrosis Transmembrane Conductance Regulator Biogenesis
- (2010) Patrick H. Thibodeau et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Quality control for unfolded proteins at the plasma membrane
- (2010) Pirjo M. Apaja et al. JOURNAL OF CELL BIOLOGY
- Correction of the Phe508 Cystic Fibrosis Transmembrane Conductance Regulator Trafficking Defect by the Bioavailable Compound Glafenine
- (2010) R. Robert et al. MOLECULAR PHARMACOLOGY
- Peripheral Protein Quality Control Removes Unfolded CFTR from the Plasma Membrane
- (2010) T. Okiyoneda et al. SCIENCE
- Cooperative Assembly and Misfolding of CFTR Domains In Vivo
- (2009) Kai Du et al. MOLECULAR BIOLOGY OF THE CELL
- Solubilizing Mutations Used to Crystallize One CFTR Domain Attenuate the Trafficking and Channel Defects Caused by the Major Cystic Fibrosis Mutation
- (2008) Luísa S. Pissarra et al. CHEMISTRY & BIOLOGY
- Molecular pathogenesis of megalencephalic leukoencephalopathy with subcortical cysts: mutations in MLC1 cause folding defects
- (2008) A. Duarri et al. HUMAN MOLECULAR GENETICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started